Skip to content
Screener

Repligen RGEN Other Non-Current Assets

Other Non-Current Assets at other companies

Danaher logo
DanaherDHR
$4.39B+18.9%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$37.87M-27.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$102.8M-0.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$51.56M-82.6%
TEC
Bio-TechneTECH
$264.37M-1.7%
Revvity logo
RevvityRVTY
$309.11M-3.7%

Other financials

Income statement

See full
Revenue$204.1M+11.9%
Gross profit$110.0M+20.7%
Operating income$14.0M+0.6%
Net income$5.0M-66.3%
EPS (diluted)$0.09-65.4%

Balance sheet

See full
Cash & equivalents$606.8M-14.4%
Total debt$690.9M+354%
Total equity$2.1B+2.4%
Total assets$3.0B+1.7%

Cash flow

See full
Operating cash flow$32.8M+14.5%
CapEx$5.3M-24.9%
Free cash flow$27.4M+27.5%

Valuation

See full
Market cap$9.25B+47.6%
Enterprise value$9.33B+63.4%
P/E222.7×
P/S12×+0.4×

Profitability

See full
Gross margin47.6%+0.9pp
Operating margin15.6%-11.0pp
Net margin17.3%-3.5pp
FCF margin22%+6.9pp

Returns & leverage

See full
Return on equity2%+1.6pp
Debt / equity0.3×+0.3×
Current ratio9.1×+0.5×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Repligen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:19 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-323773
Line itemJune 30, 2026December 31, 2025
Goodwill1,104,1831,114,408
Deferred tax assets700694
Operating lease right of use assets115,559119,538
Other noncurrent assets4,0494,913
Total assets$2,950,180$2,949,699
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$33,233$30,010

ITEM 1. Financial Statements

FAQ

What is Repligen's other non-current assets?
Repligen (RGEN) reported other non-current assets of $4.05M in Q2 2026.
How has Repligen's other non-current assets changed year-over-year?
Repligen's other non-current assets increased by 57.6% year-over-year, from $2.57M to $4.05M.
What is the long-term trend for Repligen's other non-current assets?
Over 5 years (2020 to 2025), Repligen's other non-current assets has grown at a 53.7% compound annual growth rate (CAGR), from $573K to $4.91M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Repligen's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude